Purification of IgD myeloma proteins. Plasma samples containing highly concentrated IgD myeloma proteins from four different patients were depleted of lipoproteins by the addition of heparin and MnCl2 (6). The myeloma proteins were then precipitated by the addition of ammonium sulfate to a saturation of 40%. The precipitate was dissolved in and dialyzed against 0.01 M sodium phosphate buffer, pH 8.0, and the solution was applied to a column of DEAE-ceilulose equilibrated in the same buffer. The column was eluted with a linear gradient (10 to 50 mM) of the phosphate buffer. IgD-containing fractions were pooled, dialyzed against distilled water, and lyophilized. Preparative agarose gel electrophoresis (26) was used for the final purification of the IgD myeloma proteins.
Radiolabeling of IgD. IgD was radioiodinated ('1Zs; Amer- sham International, Amersham, England) to high specific activity with lactoperoxidase coupled to polyacrylamide exactly as described by Thorell and Larsson (45) . The preparation contained approximately 0.05 mol of iodine per mol of protein.
DNA preparations. Chromosomal DNA was prepared from strain 772 by using a modification of the method of Berns and Thomas (4) . After the phenol-chloroform-isoamyl alcohol (25:24:1) extraction step, the DNA was ethanol precipitated. The DNA was dissolved in 0.1 x SSC (lx SSC is 0.15 M NaCl and 0.015 M sodium citrate) and RNase treated for 2 h at 37°C. The RNase was removed with two chloroform-isoamyl alcohol (24:1) extractions. The DNA was banded in a CsCl-ethidium bromide equilibrium gradient (32) .
Plasmid DNA and the replicative form of phage M13 from E. coli JM101 were obtained by the alkaline lysis procedure (25) followed by further purification in a CsCI-ethidium bromide gradient. In some cases plasmid DNA was prepared by using a Quiagen plasmid DNA kit (Diagen GmbH, Dusseldorf, Federal Republic of Germany).
Single-stranded DNA from phage M13 clones was prepared from single plaques as previously described (33) .
Molecular cloning of the protein D gene. An H. influenzae 772 genomic library was constructed by starting from 40 ,ug of DNA which was partially digested with 1.2 U of Sau3A for 1 h at 37°C. The cleaved DNA was fractionated on a sucrose gradient (9) . Fractions containing DNA fragments of appropriate sizes (2 to 7 kbp) were pooled, and the DNA was ligated to dephosphorylated BamHI-digested' pUC18 under standard conditions (32) . The ligation mixture was transformed into competent E. coli JM83 by high-voltage electroporation (11) with a Gene Pulser and a pulse controller apparatus, both of which were from Bio-Rad Laboratories (Richmond, Calif.). The bacteria were plated onto LB agar supplemented with ampicillin and 40 ,ug of X-Gal (5-bromo-4-chloro-3-indolyl-,3-D-galactopyranoside) per (32) . The ligation mixtures were used to transform competent E. coli cells as previously described (34) .
Progressive deletions of the recombinant plasmid pHIC348 for the sequencing procedure were produced by varying the time of exonuclease III digestion of KpnIBamHI-opened plasmid DNA (22) . For removal of the resulting single-stranded ends, mung bean nuclease was used. Both nucleases were obtained from Bethesda Research Laboratories, Inc. (Gaithersburg, Md.)
Protein extraction and electrophoretic analysis. Cells of E. coli expressing protein D were grown in LB broth supplemented with ampicillin to late logarithmic phase and then subjected to osmotic shock (23) . After removal of the periplasmic fraction the cells were lysed with NaOH (39) , and the cytoplasmic fraction was separated from the membrane fraction by centrifugation. The periplasmic and cytoplasmic proteins were precipitated with 5% trichloroacetic acid. A membrane protein extract of H. influenzae 772 was also prepared (3). The sodium lauryl sarcosinate (sarcosyl)-soluble H. influenzae membrane fraction and the E. coli fractions were loaded on a 0.1% sodium dodecyl sulfate (SDS)-11% polyacrylamide gel by using the Laemmli buffer system (29) . Protein bands were detected by staining with Coomassie blue. For identification of the protein D, the proteins were electroblotted (46) onto an Immobilon PVDF membrane (Millipore, Bedford, Mass.). The membrane was then treated as for colony immunoblots. In some experiments, filters were screened with 125I-labeled IgD in TBSova, containing 0.05% Tween 20, prior to incubation with MAbs.
DNA sequencing and sequence manipulations. The nucleotide sequence was determined by direct plasmid sequencing (7) of subclones and deletion derivatives of plasmid pHIC348 by using the chain terminaton method (40) Nucleotide sequence accession number. Sequence data have been submitted to the GenBank nucleotide sequence data base under accession no. M37487.
RESULTS
Cloning of the gene encoding protein D. DNA isolated from H. influenzae 772 was partially digested with Sau3A. Fractions containing fragments in the range of 2 to 7 kbp were collected after centrifugation on a sucrose gradient. These fragments were ligated to BamHI-cut and phosphatasetreated vector pUC18. E. coli JM83 cells, transformed with the ligation mixture by high-voltage electroporation, were selected for resistance to ampicillin. Individual colonies were transferred to nitrocellulose filters and screened with a cocktail of MAbs as described in Materials and Methods.
Among the 15,000 colonies tested, 60 were found positive. Eight positive colonies were picked, purified, and subjected to another two rounds of screening. All clones remained positive during the purification. The purified clones were tested for IgD binding with human IgD, rabbit anti-human IgD, and peroxidase-conjugated goat anti-rabbit immunoglobulins in a colony immunoassay as described in Materials and Methods. All clones were positive regarding IgD binding. Additionally, the clones were found positive when screened with the three MAbs individually. Restriction enzyme analysis of plasmid DNA from the positive clones showed that all but one clone carried a 3.3-kbp insert with two internal Sau3A sites. One clone contained an additional 2.0-kbp Sau3A fragment. One of the smaller recombinant plasmids, pHIJ32, was chosen for further characterization. A partial restriction enzyme map was established for the insert of H. influenzae DNA in pHIJ32 (Fig. 1) . To identify the region coding for protein D, restriction enzyme fragments were subcloned into pUC18. The resulting transformants were tested for expression of protein D by using colony immunoblot analysis as described above. These experiments showed that plasmids carrying a 1.9-kbp HindIII-ClaI fragment from one end of the insert allowed expression of IgD-binding protein. This recombinant plasmid, called pHIC348, was shown in Western immunoblot analysis to express an IgD-binding protein of equivalent size to the protein expressed from pHIJ32 (data not shown). Plasmid pHIC348 was kept for further experiments.
The protein D gene cloned in pHIC348 is expressed from an endogenous promoter. This was shown by cloning the HindIII-ClaI fragment of pHIJ32 in the opposite orientation in pUC19, generating pHIC349. All transformants expressed IgD binding, as would be expected if the gene is under the control of an endogenous promoter. Surprisingly, the transformants carrying pHIC349 grew poorly and autolyzed during cultivation, whereas transformants carrying pHIC348 grew just as well as bacteria carrying only the vector (data not shown). The lacZ promoter in pHIC349 is oriented in the same direction as the protein D promoter. In pHIC348 the lacZ promoter is in the opposite direction to the protein D promoter. Thus, it seems that tandem arrangement of the two promoters is lethal to the cells when grown in the presence of ampicillin.
DNA sequence analysis. The nucleotide sequences of both strands of the insert from pHIC348 were determined either by direct plasmid sequencing of subclones and deletion constructs or by subcloning restriction fragments into phages M13mpl8 and M13mpl9. Commercially available universal and reverse M13 primers were used. Sequencing was done across all restriction enzyme sites used in subcloning, and the sequencing strategy is outlined in Fig. 1 .
The DNA sequence (Fig. 2) (41) . The spacing between the center of this putative ribosome-binding site and the start codon is 13 bp in comparison with the average spacing of 10 bp in E. coli (44) . The 5'-flanking region, upstream of the proposed ribosome-binding site, shows the presence of possible promoters (38) . The sequences of the -10 region, TAAAAT (151 to 156), and the -35 region, TTGCTT (127 to 132), show homology to the consensus of E. coli promoters (38) and are identical to promoters recognized by the E. coli RNA polymerase (20) . The spacing between the putative -10 and -35 sequences is 18 bp, which is comparable with the favored value of 17 bp. A computer search did not reveal any alternative open reading frames.
Between positions 1341 and 1359 there is an inverted repeat with the potential to form a stem and loop structure. This repeat does not, however, resemble a typical rhoindependent transcription terminator (38) .
The gene for the IgD-binding protein is designated hpd. Protein structure. The hpd gene encodes a protein of 364 amino acid residues as deduced from the nucleotide sequence (Fig. 2) . The N-terminal amino acid sequence has typical characteristics of a bacterial signal peptide (49) with a stretch of hydrophilic and basic amino acids at the N terminus followed by a hydrophobic region of 13 residues and with a glycin in the hydrophobic core. The putative signal peptide ends with the consensus sequence for lipoproteins, Leu-Ala-Gly-Cys, which is recognized by the enzyme signal peptidase II (SpaseII) (53) . SpaseIl removes the signal peptide from lipoproteins by hydrolyzing the peptide bond between the glycine and cysteine residues. The primary translation product of hpd has a deduced molecular mass of 41,821 kDa. Cleavage by SpaselI would result in a protein of 346 amino acids with a calculated molecular mass of 40,068 kDa, in contrast to the estimated size of the mature protein D of approximately 42 kDa as determined by Western blot analysis (Fig. 3) . We propose a scheme for posttranslational modifications of the preprotein to account for this discrepancy (see Discussion).
A hydropathy plot by the method of Kyte and Doolittle (28) shows that protein D is mainly hydrophilic (Fig. 4) (Fig. 3 ) . The opposite relation is valid for the cytoplasmic and membrane fractions of E. coli JM83 (pHIC348), in which a relatively large amount of protein D is present, whereas the IgD binding is low (Fig. 3) peroxidase-conjugated secondary antibodies; (C) Western blot with 125I-labeled human IgD. Lanes 1, Sarcosylsoluble membrane fraction of H. influenzae 772; lanes 2, cytoplasmic fraction from E. coli JM83(pHIC348); lanes 3, periplasmic fraction from E. coli JM83(pHIC348); lanes 4, membrane fraction from E. coli JM83(pHIC348); lanes 5, cytoplasmic fraction from E. coli JM83(pUC18); lanes 6, periplasmic fraction from E. coli JM83(pUC18); lanes 7, membrane fraction from E. coli JM83(pUC18). Mw, Molecular mass markers (in kilodaltons). All samples were boiled (100°C) in the presence of 2-mercaptoethanol for 5 min prior to loading. Coomassie blue stain (Fig. 3A) . Thus, the amount of protein D in the periplasmic fraction is small compared with the amounts of protein D in the cytoplasmic and membrane fractions.
Protein D is located on the surface of both H. influenzae and E. coli JM83 carrying pHIC348. This was shown in a binding assay to intact cells using '25I-labeled IgD (14) . H. influenzae 772 bound 79% of the added radiolabeled IgD and E. coli JM83(pHIC348) bound 34%, whereas E. coli JM83(pUC18) exhibited only 2% binding of the added amount of radiolabeled IgD.
The nucleotide sequence and the deduced amino acid sequence of the hpd gene were compared with known sequences of other proteins to determine homology by using a computer search in the EMBL and GenBank data libraries. No homology to other proteins was found apart from similarities in the signal sequence.
DISCUSSION
The present investigation describes the isolation and characterization of the hpd gene encoding for protein D from H. influenzae 772. The deduced amino acid sequence reveals several interesting features (Fig. 2) . The N-terminal amino acid sequence resembles a bacterial signal peptide which contains the consensus sequence for lipoproteins, Leu-AlaGly-Cys (53) . The unmodified precursor of protein D contains a total of 364 amino acid residues with a calculated molecular mass of 41,821 Da. For lipoproteins which have the recognition sequence for Spasell, Leu-Ala-Gly-Cys, or homologous sequences thereof, the posttranslational cleavage and processing site is at the cysteine residue (53) . The modifications of the prelipoprotein take place in the cytoplasmic membrane and might include the transfer of a glyceryl moiety to the sulfhydryl group of the cysteine, 0 acylation of the glyceryl cysteine, proteolytic removal of the signal peptide and the attachment of a fatty acid to the a-NH2 group of the cysteine. The fully modified and processed lipoprotein is then translocated to the outer membrane. The calculated molecular weight of protein D after cleavage with Spasell is 40,068. The apparent molecular mass of protein D, as determined by SDS-PAGE and Western blot analysis, is 42 kDa (Fig. 3) . The difference of 1.93 kDa may be accounted for in part by the posttranslational modifications mentioned above. No N-terminal amino acid could be identified in the mature protein D of H. influenzae 772 (38a), which also is expected with the above-mentioned posttranslational process with its acylation of the a-amino group of the putative amino-terminal cysteinyl residue. The indications that protein D is a lipoprotein are the presence of the consensus sequence for Spasell and its membrane localization (Fig. 3) . Apart from the hydrophobic putative signal sequence, protein D is mainly hydrophilic (Fig. 4) and contains no typical membrane-spanning region (50) . It is therefore possible that protein D is attached to the membrane with the modified N-terminal cysteine residue in the same manner as has been reported for other H. influenzae outer membrane proteins (10, 35 
